Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-5.99M
-
Total reported value, excl. options
-
$0
-
Value change
-
-$2.57M
-
Number of sells
-
-24
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q1 2024
25 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q1 2024.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 386M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include Aristides Capital LLC (0 shares), US BANCORP \DE\ (0 shares), RHUMBLINE ADVISERS (0 shares), TWO SIGMA SECURITIES, LLC (0 shares), STONEHILL CAPITAL MANAGEMENT LLC (0 shares), BANK OF AMERICA CORP /DE/ (0 shares), MILLENNIUM MANAGEMENT LLC (0 shares), Whitefort Capital Management, LP (0 shares), BECKER CAPITAL MANAGEMENT INC (0 shares), and Dynamic Advisor Solutions LLC (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.